These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 940955

  • 1. Disposition kinetics of dihydroquinidine following quinidine administration.
    Ueda CT, Williamson BJ, Dzindzio BS.
    Res Commun Chem Pathol Pharmacol; 1976 Jun; 14(2):215-25. PubMed ID: 940955
    [Abstract] [Full Text] [Related]

  • 2. The bioavailability and kinetics of dihydroquinidine in patients with heart disease.
    Regazzi Bonora M, Salerno JA, Rondanelli R, Cristiani D, Chimienti M.
    Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):212-8. PubMed ID: 7095920
    [Abstract] [Full Text] [Related]

  • 3. Disposition kinetics of quinidine.
    Ueda CT, Hirschfeld DS, Scheinman MM, Rowland M, Williamson BJ, Dzindzio BS.
    Clin Pharmacol Ther; 1976 Jan; 19(1):30-6. PubMed ID: 1245091
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of dihydroquinidine in congestive heart failure patients after intravenous quinidine administration.
    Ueda CT, Dzindzio BS.
    Eur J Clin Pharmacol; 1979 Sep; 16(2):101-5. PubMed ID: 499305
    [Abstract] [Full Text] [Related]

  • 5. Concentration-time effects of quinidine disposition kinetics in rhesus monkeys.
    Ueda CT, Ballard B, Rowland M.
    J Pharmacol Exp Ther; 1977 Mar; 200(3):459-68. PubMed ID: 403278
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of dihydroquinidine on in vitro and in vivo quinidine disposition.
    Ueda CT.
    Biochem Pharmacol; 1980 Mar 01; 29(5):737-40. PubMed ID: 20227949
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative in vitro electrophysiology of quinidine, its major metabolites and dihydroquinidine.
    Thompson KA, Blair IA, Woosley RL, Roden DM.
    J Pharmacol Exp Ther; 1987 Apr 01; 241(1):84-90. PubMed ID: 3572799
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic analysis of intravenously and orally administered quinidine in horses.
    McGuirk SM, Muir WW, Sams RA.
    Am J Vet Res; 1981 Jun 01; 42(6):938-42. PubMed ID: 7283244
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of hydroxy-3(S)-dihydroquinidine in healthy volunteers after intravenous and oral administration.
    Jaillon P, Poirier JM, Lecocq B, Jarreau C, Pays M, Richard MO, Cheymol G.
    Eur J Drug Metab Pharmacokinet; 1986 Jun 01; 11(3):233-8. PubMed ID: 3816879
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic analysis of intravenously and orally administered quinidine in cows.
    McGuirk SM, Muir WW, Sams RA.
    Am J Vet Res; 1981 Sep 01; 42(9):1482-7. PubMed ID: 7325456
    [Abstract] [Full Text] [Related]

  • 16. Absorption of quinidine and dihydroquinidine in humans.
    Hailey DM, Lea AR, Coles DM, Heaume PE, Smith WJ.
    Eur J Clin Pharmacol; 1981 Sep 01; 21(3):195-9. PubMed ID: 7318878
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Determination of the interaction of 3S-hydroxy-10,11-dihydroquinidine on the pharmacokinetics and pharmacodynamics of warfarin.
    Trenk D, Möhrke W, Warth L, Jähnchen E.
    Arzneimittelforschung; 1993 Aug 01; 43(8):836-41. PubMed ID: 8216438
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of caffeine on the oral absorption and disposition of quinidine.
    Zeller FP, Ueda CT, Wulf BG, Meyers DG.
    Clin Pharm; 1984 Aug 01; 3(1):72-5. PubMed ID: 6697677
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.